Multidrug-resistant Salmonella Typhi among symptomatic and asymptomatic children in informal settlements in Nairobi, Kenya.
Humans
Kenya
/ epidemiology
Salmonella typhi
/ genetics
Child
Drug Resistance, Multiple, Bacterial
/ genetics
Typhoid Fever
/ microbiology
Child, Preschool
Anti-Bacterial Agents
/ pharmacology
Male
Adolescent
Female
Infant
Microbial Sensitivity Tests
Feces
/ microbiology
Prevalence
Carrier State
/ microbiology
Salmonella Typhi
Asymptomatic
Informal settlements
Multi drug resistance
Phenotypes
Symptomatic
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
25 Oct 2024
25 Oct 2024
Historique:
received:
15
03
2024
accepted:
22
10
2024
medline:
26
10
2024
pubmed:
26
10
2024
entrez:
25
10
2024
Statut:
epublish
Résumé
The emergence and persistence of multidrug-resistant (MDR) Salmonella Typhi (S. Typhi) infections is a significant global health problem. The carrier state of typhoid makes it prudent to conduct routine surveillance for both acute cases and carriers especially those caused by MDR S. Typhi. We report on the prevalence of MDR S. Typhi, resistance phenotypes and antimicrobial resistance genes detected in symptomatic and asymptomatic children living in informal settlements in Nairobi, Kenya. 215 archived presumed S. Typhi isolates from stool samples provided by children ≤ 16 years collected from 2013 to 2018 were revived in May, 2022 and confirmed using culture and antisera serotyping. The Kirby Bauer disc diffusion technique was used to test the S. Typhi against 14 antibiotics. The MDR S. Typhi (resistant to ampicillin, chloramphenicol and sulfamethoxazole trimethoprim) which in addition were also resistant to either a cephalosporin or a fluoroquinolone were analyzed for Beta lactams and quinolone resistance genes using polymerase chain reaction. A total of 215 isolates were confirmed to be positively S. Typhi; of these, 105 (49%) and 110 (51%) were from symptomatic and asymptomatic children respectively. On average, S. Typhi resistance from asymptomatic and symptomatic children against 1st line drugs was observed at; 77% &70%, ampicillin; 60% & 64%, sulfamethoxazole-trimethoprim, and 45% & 54%, chloramphenicol respectively. Multi drug resistance was observed in 90 (42%) of the isolates, of these, 44 (49%) were isolated from symptomatic and 46 (51%) from asymptomatic children. Fifteen resistance phenotypes (p) were observed with, ampicillin/chloramphenicol/sulfamethoxazole-trimethoprim/nalidixic acid (amp/chl/sxt/na) as the most common among the symptomatic 43/90 (48%) and asymptomatic 55/90 (61%) children. The bla The carriage of MDR S. Typhi among the asymptomatic children is concerning as they can act as potential transmitters of the typhoid disease to unsuspecting children. These study findings highlight the need for continued surveillance of antimicrobial resistance and mass immunization of children living in these urban informal areas.
Sections du résumé
BACKGROUND
BACKGROUND
The emergence and persistence of multidrug-resistant (MDR) Salmonella Typhi (S. Typhi) infections is a significant global health problem. The carrier state of typhoid makes it prudent to conduct routine surveillance for both acute cases and carriers especially those caused by MDR S. Typhi. We report on the prevalence of MDR S. Typhi, resistance phenotypes and antimicrobial resistance genes detected in symptomatic and asymptomatic children living in informal settlements in Nairobi, Kenya.
METHODS
METHODS
215 archived presumed S. Typhi isolates from stool samples provided by children ≤ 16 years collected from 2013 to 2018 were revived in May, 2022 and confirmed using culture and antisera serotyping. The Kirby Bauer disc diffusion technique was used to test the S. Typhi against 14 antibiotics. The MDR S. Typhi (resistant to ampicillin, chloramphenicol and sulfamethoxazole trimethoprim) which in addition were also resistant to either a cephalosporin or a fluoroquinolone were analyzed for Beta lactams and quinolone resistance genes using polymerase chain reaction.
RESULTS
RESULTS
A total of 215 isolates were confirmed to be positively S. Typhi; of these, 105 (49%) and 110 (51%) were from symptomatic and asymptomatic children respectively. On average, S. Typhi resistance from asymptomatic and symptomatic children against 1st line drugs was observed at; 77% &70%, ampicillin; 60% & 64%, sulfamethoxazole-trimethoprim, and 45% & 54%, chloramphenicol respectively. Multi drug resistance was observed in 90 (42%) of the isolates, of these, 44 (49%) were isolated from symptomatic and 46 (51%) from asymptomatic children. Fifteen resistance phenotypes (p) were observed with, ampicillin/chloramphenicol/sulfamethoxazole-trimethoprim/nalidixic acid (amp/chl/sxt/na) as the most common among the symptomatic 43/90 (48%) and asymptomatic 55/90 (61%) children. The bla
CONCLUSION
CONCLUSIONS
The carriage of MDR S. Typhi among the asymptomatic children is concerning as they can act as potential transmitters of the typhoid disease to unsuspecting children. These study findings highlight the need for continued surveillance of antimicrobial resistance and mass immunization of children living in these urban informal areas.
Identifiants
pubmed: 39455953
doi: 10.1186/s12879-024-10104-w
pii: 10.1186/s12879-024-10104-w
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1205Subventions
Organisme : National Institute of Allergy and Infectious Diseases of the National Institutes of Health
ID : R01AI099525
Informations de copyright
© 2024. The Author(s).
Références
Centre for Disease Control. Typhoid and paratyphoid. Travellers Health. 2020;4:78.
(WHO). (2017). Typhoid Fever. http://www.who.int/ith/vaccines/typhoidfever/en/
(WHO). (2019). Vaccines and disease, Typhoid. Immunization, Vaccine and Biologicals Newsletter.
Kim JH, Im J, Parajulee P, Holm M, Cruz Espinoza LM, Poudyal N, Mogeni OD, Marks F. A systematic review of typhoid fever occurrence in Africa. Clin Infect Dis. 2019;69(Suppl 6):S492–8. https://doi.org/10.1093/cid/ciz525 . PMID: 31665777; PMCID: PMC6821235.
doi: 10.1093/cid/ciz525
pubmed: 31665777
pmcid: 6821235
Simiyu K, Jamka L. Typhoid in a Kenyan village: its impact, its Prevention. Am J Trop Med Hyg. 2018;99(5):1112–3. https://doi.org/10.4269/ajtmh.18-0537 . PMID: 30404685; PMCID: PMC6221209.
doi: 10.4269/ajtmh.18-0537
pubmed: 30404685
pmcid: 6221209
Breiman RF, Cosmas L, Njuguna H, Audi A, Black B, Ochieng JB, Wamola N, Bigogo GM, Awiti G, Tabu WC, Burke H, Williamson OJ, Mintz D, E. and, Feikin R. D. Population-Based Incidence of Typhoid Fever in an Urban Informal Settlement and a Rural Area in Kenya: Implications for Typhoid Vaccine Use in Africa. PLoS ONE, 2012;1: 291–299.
Kariuki S, Gilks C, Revathi G, Hart CA. Genotypic analysis of multidrug-resistant Salmonella enterica serovar typhi, Kenya. Emergence Infect Dis. 2000;10:606–16.
Kariuki S, Revathi G, Kiiru J, Mengo DM, Mwituria J, Muyodi J, Gordon G. Typhoid in Kenya is associated with a dominant multidrug-resistant Salmonella enterica serovar typhi haplotype that is also widespread in Southeast Asia. J Clin Microbiol. 2010;48:2171–6.
doi: 10.1128/JCM.01983-09
pubmed: 20392916
pmcid: 2884483
Mengo D, Kariuki S, Muigai A. Salmonella enteric serovar Typhi in Nairobi, Kenya from 2004 to 2006. J Infect Developing Ctries. 2010;6:393–6.
doi: 10.3855/jidc.503
Parry, C. M., Thompson, C., Vinh, H., Chinh, N.T., Phuong, L.T., Ho,V.A., Hien, T.T.,… Baker, S. Risk factors for the development of severe typhoid fever in Vietnam. BMC Infectious Diseases, 2014;14, 73–76.
Feasey NA, Gaskell K, Wong V, Msefula C, Selemani G, Kumwenda S, Heyderman RS. Rapid Emergence of Multidrug Resistant, H58-Lineage Salmonella Typhi in Blantyre,Malawi. PLoS Negl Trop Dis. 2015;9:374–9.
doi: 10.1371/journal.pntd.0003748
Akinyemi KO, Smith SI, Oyefolu AB, &Coker AO. Multidrug resistance in Salmonella enterica Serovar Typhi isolated from patients with typhoid fever complications in Lagos. Nigeria Public Health. 2005;4:321–7.
doi: 10.1016/j.puhe.2004.04.009
Mogasale V, Maskery B, Ochiai RL, Lee JS, Ramani E, Park JK. Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment. Lancet Global Health. 2014;10:570–80.
doi: 10.1016/S2214-109X(14)70301-8
Kavai S, Kangogo M, Muigai A. Analysis of trends in Resistance to fluoroquinolones and Extended Spectrum Beta-Lactams among Salmonella Typhi isolates obtained from patients at four outpatient clinics in Nairobi County, KenyaNo Title. Adv Microbiol. 2018;8:578–88.
doi: 10.4236/aim.2018.87038
Parry CM, Wijedoru L, Arjyal A, Baker S. The utility of diagnostic tests for enteric fever in endemic locations. Expert Reviews Antimicrobials Infect Therapy. 2011;9:711–25.
doi: 10.1586/eri.11.47
Crump JA, Mintz ED. Global trends in typhoid and paratyphoid fever. Clin Infect Dis. 2010;50:241–6.
doi: 10.1086/649541
pubmed: 20014951
Kariuki S, Mbae C, Van Puyvelde S, Onsare R, Kavai S, Wairimu C, Ngetich R, Clemens J, Dougan G. High relatedness of invasive multi-drug resistant non-typhoidal Salmonella genotypes among patients and asymptomatic asymptomatic in endemic informal settlements in Kenya. PLoS Negl Trop Dis, 2020;14, e0008440.
Gunn JS, Joanna M, Marshall S, Baker S, Dongol, Richelle C, Charles. E. T. R. Salmonella chronic carriage: epidemiology, diagnosis, and gallbladder persistence. Trends Microbiol. 2014;22(11):648–55.
doi: 10.1016/j.tim.2014.06.007
pubmed: 25065707
pmcid: 4252485
CLSI supplement M100, Wayne PA. Clinical and Laboratory Standards Institute; 2022.
Kariuki S, Gordon MA, Feasey N, Parry CM, Trust W, Campus G, Kingdom U, Health G, Wellcome L, Clinical T, Street K, Street K, Health G. Antimicrobial resistance and management of invasive Salmonella disease. Vaccine. 2015;33:21–9.
doi: 10.1016/j.vaccine.2015.03.102
Mirza S, Kariuki S, Mamun KZ, Beeching NJ. A. Analysis of plasmid and chromosomal DNA of multidrug-resistant Salmonella enterica serovar Typhi from Asia. J Clin Microbiol. 2000;38:1449–52.
doi: 10.1128/JCM.38.4.1449-1452.2000
pubmed: 10747124
pmcid: 86462
Mbae Cecilia M, Mwangi N, Gitau T, Irungu F, Muendo Z, Wakio R, Wambui S, Kavai R, Onsare C, Wairimu R, Ngetich F, Njeru S, Van Puyvelde J, Clemens GD. Factors associated with the occurrence of salmonellosis among children living in Mukuru slum, an urban informal settlement in Kenya. BMC Infect Dis. 2020;20:422.
doi: 10.1186/s12879-020-05134-z
pubmed: 32552753
pmcid: 7302364
Jung SH. Stratified Fisher’s exact test and its sample size calculation. Biom J. 2014;56. https://doi.org/10.1002/bimj.201300048 .
Lutterloh E, Likaka A, Sejvar J, Manda R, Naiene J, Monroe SS, et al. Multidrug-resistant typhoid fever with neurologic findings on the Malawi-Mozambique Border. Clin Infect Dis. 2012;54(8):1100–6.
doi: 10.1093/cid/cis012
pubmed: 22357702
Lunguya O, Lejon V, Phoba M-F, Bertrand S, Vanhoof R, Verhaegen J, et al. Salmonella Typhi in the Democratic Republic of the Congo: fluoroquinolone decreased susceptibility on the rise. PLoS Negl Trop Dis. 2012;6(11):e1921.
doi: 10.1371/journal.pntd.0001921
pubmed: 23166855
pmcid: 3499407
Samuel Kariuki ZA, Dyson C, Mbae R, Ngetich, Susan M, Kavai C, Wairimu S, Anyona N, Gitau RS, Onsare B, Ongandi S, Duchene M, Ali JD, Clemens, Kathryn E. Holt, Gordon Dougan multiple introductions of multidrug-resistant typhoid associated with acute infection and asymptomatic carriage. Kenya eLife. 2021;10:e67852.
doi: 10.7554/eLife.67852
pubmed: 34515028
Arif M, Tanmoy E, Westeel KD, Bruyne J, Goris A, Rajoharison, Mohammad SI, Sajib A, van Belkum SK, Saha. Florence Komurian-Pradel, Hubert P. Endtz Salmonella enterica Serovar Typhi in Bangladesh: Exploration of Genomic Diversity and Antimicrobial Resistance, ASM Journals mBio, 2018; Vol. 9, No. 6 https://doi.org/10.1128/mbio.02112-18